Clifford Chance has advised the joint sponsors CICC and CMBI on the deal. Mobvoi Inc. has completed the initial public offering and listing on the Main Board...
You must be a Standard 1 Year member to access this content.
Clifford Chance acted as the legal advisors to the sole sponsor CICC and underwriters. Sichuan Baicha Baidao Industrial Co., Ltd. (ChaPanda) completed the US$330 Million IPO...
You must be a Standard 1 Year member to access this content.
Linklaters and King & Wood Mallesons advised the joint sponsors and underwriters in connection with the offering. Clifford Chance advised Beijing-based Sunshine Insurance Group. China’s Sunshine...
You must be a Standard 1 Year member to access this content.
Skadden, Arps, Slate, Meagher & Flom LLP acted as legal advisers to Zhihu as to Hong Kong and US laws and Han Kun Law Offices as...
You must be a Standard 1 Year member to access this content.
Harneys acted as British Virgin Islands and Cayman Islands counsel for the successful listing of the shares of Arrail Group Limited on the Main Board of...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised Lepu Biopharma Co., Ltd. on the deal. Herbert Smith Freehills has advised CICC and Morgan Stanley. The Joint Sponsors are CICC and...
You must be a Standard 1 Year member to access this content.
Herbert Smith Freehills advised the joint sponsors involved in the IPO. Clifford Chance advised SF Intra-City Industrial Co. Ltd. SF Intra-city operates China’s largest third-party on-demand...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Zylox-Tonbridge Medical Technology Co., Ltd., while Clifford Chance has advised Morgan Stanley, CLSA and other underwriters. Grandall Advised Zylox-Tonbridge. JunHe advised Zylox-Tonbridge. The...
You must be a Standard 1 Year member to access this content.
Walkers acted as Cayman Islands counsel to Bilibili Inc. in connection with its US$2.6 billion global offering of 25 million shares on the Main Board of...
You must be a Standard 1 Year member to access this content.
Clifford Chance, Maples and Calder JunHe advised SciClone Pharmaceuticals on its US$281 million initial public offering and listing on the main board of the Hong Kong...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised the joint sponsors Bank of America, UBS and CLSA, and the underwriters on JD.com’s US$3.87 billion initial public offeringand secondary listing on...
You must be a Standard 1 Year member to access this content.
